Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 63

1.

Identification of the Significant Involvement and Mechanistic Role of CYP3A4/5 in Clopidogrel Bioactivation.

Zhu Y, Zhou J.

ACS Med Chem Lett. 2012 Sep 9;3(10):844-9. doi: 10.1021/ml3002067. eCollection 2012 Oct 11.

PMID:
24900388
[PubMed]
Free PMC Article
2.

Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases.

Karaźniewicz-Łada M, Danielak D, Burchardt P, Kruszyna L, Komosa A, Lesiak M, Główka F.

Clin Pharmacokinet. 2014 Feb;53(2):155-64. doi: 10.1007/s40262-013-0105-2.

PMID:
24127209
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Applied pharmacogenomics in cardiovascular medicine.

Weeke P, Roden DM.

Annu Rev Med. 2014;65:81-94. doi: 10.1146/annurev-med-101712-122545. Epub 2013 Oct 2.

PMID:
24111889
[PubMed - in process]
Free PMC Article
4.

CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factors.

Sukasem C, Tunthong R, Chamnanphon M, Santon S, Jantararoungtong T, Koomdee N, Prommas S, Puangpetch A, Vathesatogkit P.

Pharmgenomics Pers Med. 2013 Aug 22;6:85-91. doi: 10.2147/PGPM.S42332. eCollection 2013.

PMID:
24019752
[PubMed]
Free PMC Article
5.

Indirect estimation of the comparative treatment effect in pharmacogenomic subgroups.

Sorich MJ, Coory M, Pekarsky BA.

PLoS One. 2013 Aug 27;8(8):e72256. doi: 10.1371/journal.pone.0072256. eCollection 2013.

PMID:
24015225
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The new biology: a bridge to clinical cardiology.

Louridas G, Lourida K.

Hippokratia. 2012 Apr;16(2):106-12.

PMID:
23935264
[PubMed]
Free PMC Article
7.

Clopidogrel Resistance by P2Y12 Platelet Function Testing in Patients Undergoing Neuroendovascular Procedures: Incidence of Ischemic and Hemorrhagic Complications.

Nordeen JD, Patel AV, Darracott RM, Johns GS, Taussky P, Tawk RG, Miller DA, Freeman WD, Hanel RA.

J Vasc Interv Neurol. 2013 Jun;6(1):26-34.

PMID:
23826440
[PubMed - as supplied by publisher]
Free PMC Article
8.

Pharmacogenomics of anti-platelet and anti-coagulation therapy.

Fisch AS, Perry CG, Stephens SH, Horenstein RB, Shuldiner AR.

Curr Cardiol Rep. 2013 Jul;15(7):381. doi: 10.1007/s11886-013-0381-3. Review.

PMID:
23797323
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.

Scott SA, Sangkuhl K, Stein CM, Hulot JS, Mega JL, Roden DM, Klein TE, Sabatine MS, Johnson JA, Shuldiner AR; Clinical Pharmacogenetics Implementation Consortium.

Clin Pharmacol Ther. 2013 Sep;94(3):317-23. doi: 10.1038/clpt.2013.105. Epub 2013 May 22.

PMID:
23698643
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Pharmacogenomics of anti-platelet therapy: how much evidence is enough for clinical implementation?

Perry CG, Shuldiner AR.

J Hum Genet. 2013 Jun;58(6):339-45. doi: 10.1038/jhg.2013.41. Epub 2013 May 23. Review.

PMID:
23697979
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Pharmacogenomics and cardiovascular disease.

Weeke P, Roden DM.

Curr Cardiol Rep. 2013 Jul;15(7):376. doi: 10.1007/s11886-013-0376-0. Review.

PMID:
23689943
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Pharmacogenetics and cardiovascular disease--implications for personalized medicine.

Johnson JA, Cavallari LH.

Pharmacol Rev. 2013 May 17;65(3):987-1009. doi: 10.1124/pr.112.007252. Print 2013 Jul. Review.

PMID:
23686351
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Platelet function testing to predict hyporesponsiveness to clopidogrel in patients with chest pain seen in the emergency department.

Sharma RK, Erickson SW, Sharma R, Voelker DJ, Reddy HK, Dod H, Marsh JD.

Vasc Health Risk Manag. 2013;9:187-93. doi: 10.2147/VHRM.S43909. Epub 2013 May 1.

PMID:
23662064
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Polymorphisms of MDR1, CYP2C19 and P2Y12 genes in Indian population: effects on clopidogrel response.

Shalia KK, Shah VK, Pawar P, Divekar SS, Payannavar S.

Indian Heart J. 2013 Mar-Apr;65(2):158-67. doi: 10.1016/j.ihj.2013.02.012. Epub 2013 Feb 24.

PMID:
23647895
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

CYP2C19 phenotype, stent thrombosis, myocardial infarction, and mortality in patients with coronary stent placement in a Chinese population.

Xie X, Ma YT, Yang YN, Li XM, Ma X, Fu ZY, Zheng YY, Chen BD, Liu F.

PLoS One. 2013;8(3):e59344. doi: 10.1371/journal.pone.0059344. Epub 2013 Mar 12.

PMID:
23555019
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?

Oprea AD, Popescu WM.

Cardiol Res Pract. 2013;2013:195456. doi: 10.1155/2013/195456. Epub 2013 Feb 19.

PMID:
23533940
[PubMed]
Free PMC Article
17.

Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?

Shahin MH, Johnson JA.

Curr Opin Cardiol. 2013 May;28(3):305-14. doi: 10.1097/HCO.0b013e32835f0bbc. Review.

PMID:
23478884
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The CYP2C19(∗)1/(∗)2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian Volunteers.

Nasyuhana Sani Y, Sheau Chin L, Luen Hui L, Mohd Redhuan Shah Edwin NE, Teck Hwa G, Serebruany VL, Kah Hay Y.

Cardiol Res Pract. 2013;2013:128795. doi: 10.1155/2013/128795. Epub 2013 Jan 31.

PMID:
23431496
[PubMed]
Free PMC Article
19.

Controversies in the use & implementation of drug-eluting stent technology.

Itagaki BK, Brar SS.

Indian J Med Res. 2012 Dec;136(6):926-41. Review.

PMID:
23391788
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine.

Lee SJ.

Front Genet. 2013 Feb 1;3:318. doi: 10.3389/fgene.2012.00318. eCollection 2012.

PMID:
23378847
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk